Skip to main content
. 2013 Aug 13;8(8):e71679. doi: 10.1371/journal.pone.0071679

Figure 7. Inhibition of MMP2 in vitro inhibits the ability of AFSC to reduce CCL2 levels following AECII bleomycin injury.

Figure 7

(A) CCL2 ELISA of conditioned media from in vitro injury of AECII with 100 mU/ml of bleomycin with AFSC co-culture with and without the addition of an MMP2 inhibitor. (B) qPCR analysis of cellular MMP2 expression from in vitro injury of AECII with 100 mU/ml of bleomycin with AFSC co-culture with and without the addition of an MMP2 inhibitor. (C) Proposed mechanism of AFSC mediated CCL2 modulation within the alveolus.